Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-30

FDA Approved: HYDRALAZINE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hydralazine Hydrochloride (HYDRALAZINE HYDROCHLORIDE) from Nivagen Pharmaceuticals, Inc. under an Abbreviated New Dr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydralazine hydrochloride (Hydralazine hydrochloride)

Snippet

SUPPL AP for HYDRALAZINE (HYDRALAZINE HYDROCHLORIDE)